Clinical Science| Volume 207, ISSUE 6, P877-881, June 2014

The better effect of Roux-en-Y gastrointestinal reconstruction on blood glucose of nonobese type 2 diabetes mellitus patients

Published:October 18, 2013DOI:



      Given the role of gastrointestinal reconstruction, we investigated whether Roux-en-Y gastrointestinal reconstruction (RYGR) and Billroth I reconstruction (B1R) can improve glucose in nonobese type 2 diabetes mellitus patients.


      Seventy-six nonobese type 2 diabetes mellitus patients underwent open subtotal gastrectomy with RYGR and B1R between January 2005 and January 2010 in our hospital. Besides demographic data, preoperative weight, glucose, hemoglobin A1c, ghrelin, and glucagon-like peptide 1 were determined.


      As defined previously, 2 of 35 patients with RYGR were cured, 5 patients were controlled, and 10 patients were improved; similarly, 2 of 41 patients with B1R were controlled, and 3 patients improved 12 months after surgery. The fasting glucose and hemoglobin A1c decreased more significantly in RYGR patients (P < .05). Moreover, a higher fasting plasma GLP-1 level in RYGR patients and lower ghrelin in B1R patients were noted after surgery (P < .05).


      RYGR shows a more effective amelioration in nonobese type 2 diabetes mellitus patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Narayan K.M.
        • Boyle J.P.
        • Geiss L.S.
        • et al.
        Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.
        Diabetes Care. 2006; 29: 2114-2116
        • Roglic G.
        • Unwin N.
        • Bennett P.H.
        • et al.
        The burden of mortality attributable to diabetes: realistic estimates for the year 2000.
        Diabetes Care. 2005; 28: 2130-2135
        • Patriti A.
        • Aisa M.C.
        • Annetti C.
        • et al.
        How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
        Surgery. 2007; 142: 74-85
        • Boza C.
        • Munoz R.
        • Salinas J.
        • et al.
        Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients.
        Obes Surg. 2011; 21: 1330-1336
        • Schauer P.R.
        • Ikramuddin S.
        • Gourash W.
        • et al.
        Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.
        Ann Surg. 2000; 232: 515-529
        • Pories W.J.
        • Swanson M.S.
        • MacDonald K.G.
        • et al.
        Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.
        Ann Surg. 1995; 222 (discussion, 350–2): 339-350
        • Schauer P.R.
        • Burguera B.
        • Ikramuddin S.
        • et al.
        Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.
        Ann Surg. 2003; 238 (discussion, 484–5): 467-484
        • Hussain A.
        • Mahmood H.
        • El-Hasani S.
        Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?.
        Can J Surg. 2009; 52: E269-E275
        • Thaler J.P.
        • Cummings D.E.
        Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery.
        Endocrinology. 2009; 150: 2518-2525
        • Tam C.S.
        • Berthoud H.R.
        • Bueter M.
        • et al.
        Could the mechanisms of bariatric surgery hold the key for novel therapies? Report from a Pennington Scientific Symposium.
        Obes Rev. 2011; 12: 984-994
        • DePaula A.L.
        • Macedo A.L.
        • Mota B.R.
        • et al.
        Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29.
        Surg Endosc. 2009; 23: 1313-1320
        • Gill R.S.
        • Sharma A.M.
        • Al-Adra D.P.
        • et al.
        The impact of bariatric surgery in patients with type-2 diabetes mellitus.
        Curr Diabetes Rev. 2011; 7: 185-189
        • Buchwald H.
        • Estok R.
        • Fahrbach K.
        • et al.
        Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.
        Am J Med. 2009; 122: 248-256e5
        • Gill R.S.
        • Karmali S.
        • Sharma A.M.
        Treating type 2 diabetes mellitus with sleeve gastrectomy in obese patients.
        Obesity (Silver Spring). 2011; 19: 701-702
        • Kiong K.L.
        • Ganesh R.
        • Cheng A.K.
        • et al.
        Early improvement in type 2 diabetes mellitus post Roux-en-Y gastric bypass in Asian patients.
        Singapore Med J. 2010; 51: 937-943
        • Potenza M.
        • Rayfield E.J.
        Targeting the incretin system in type 2 diabetes mellitus.
        Mt Sinai J Med. 2009; 76: 244-256
        • Pories W.J.
        • Albrecht R.J.
        Etiology of type II diabetes mellitus: role of the foregut.
        World J Surg. 2001; 25: 527-531
        • Rubino F.
        Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis.
        Diabetes Care. 2008; 31: S290-S296
        • Kirchner H.
        • Tong J.
        • Tschop M.H.
        • et al.
        Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants.
        Am J Physiol Endocrinol Metab. 2010; 298: E909-9
        • Peterli R.
        • Steinert R.E.
        • Woelnerhanssen B.
        • et al.
        Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.
        Obes Surg. 2012; 22: 740-748
        • Drucker D.J.
        • Nauck M.A.
        The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
        Lancet. 2006; 368: 1696-1705
        • de Carvalho C.P.
        • Marin D.M.
        • de Souza A.L.
        • et al.
        GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.
        Obes Surg. 2009; 19: 313-320
        • Cummings B.P.
        • Strader A.D.
        • Stanhope K.L.
        • et al.
        Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat.
        Gastroenterology. 2010; 138 (2446.e1): 2437-2446
        • Chen W.
        • Yan Z.
        • Liu S.
        • et al.
        The changes of pro-opiomelanocortin neurons in type 2 diabetes mellitus rats after ileal transposition: the role of POMC neurons.
        J Gastrointest Surg. 2011; 15: 1618-1624
        • Wang R.
        • Liu X.
        • Hentges S.T.
        • et al.
        The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides.
        Diabetes. 2004; 53: 1959-1965
        • Ibrahim N.
        • Bosch M.A.
        • Smart J.L.
        • et al.
        Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels.
        Endocrinology. 2003; 144: 1331-1340
        • Parton L.E.
        • Ye C.P.
        • Coppari R.
        • et al.
        Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity.
        Nature. 2007; 449: 228-232
        • Tanaka S.
        • Matsuo K.
        • Matsumoto H.
        • et al.
        Clinical outcomes of Roux-en-Y and Billroth I reconstruction after a distal gastrectomy for gastric cancer: what is the optimal reconstructive procedure?.
        Hepatogastroenterology. 2011; 58: 257-262